Evidence map›Paper›PMID 33006754›Full record

ArticleJournal of racial and ethnic health disparities2021

Implementation of Universal Colorectal Cancer Screening for Lynch Syndrome in Hispanics Living in Puerto Rico.

Isabel Sierra, Julyann Pérez-Mayoral, Kathia Rosado, Valerie Maldonado, Kimberly Alicea-Zambrana, José S Reyes, Marla Torres, Luis Tous, Nicolas Lopéz-Acevedo, Yaritza Diaz-Algorrí and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Knowledge, Attitudes, and Beliefs About Colorectal Cancer Screening in Puerto Rico.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Isabel SierraDivision of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Julyann Pérez-MayoralDivision of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Kathia RosadoHato Rey Pathology Laboratories, San Juan, Puerto Rico.
Valerie MaldonadoDepartment of Allied Health Sciences, San Juan Bautista School of Medicine, Caguas, Puerto Rico.
Kimberly Alicea-ZambranaDepartment of Biology, University of Puerto Rico Rio Piedras Campus, San Juan, Puerto Rico.
José S ReyesColorectal Cancer Surgery Clinic, San Juan, Puerto Rico.
Marla TorresColorectal Cancer Surgery Clinic, San Juan, Puerto Rico.
Luis TousColorectal Cancer Surgery Clinic, San Juan, Puerto Rico.
Nicolas Lopéz-AcevedoColorectal Cancer Surgery Clinic, San Juan, Puerto Rico.
Yaritza Diaz-AlgorríDepartment of Allied Health Sciences, San Juan Bautista School of Medicine, Caguas, Puerto Rico.
Victor Carlo-ChevereDepartment of Medicine, University of Puerto Rico Medical Sciences Campus, PO BOX 365067, San Juan, 00936, Puerto Rico.
Segundo Rodriguez-QuilichiniDepartment of Surgery, University of Puerto Rico Medical Sciences Campus, San Juan, PR, Puerto Rico.
Marcia Cruz-CorreaDivision of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. marcia.cruz1@upr.edu.
San Juan Bautista School of Medicine · PRUniversity of Puerto Rico, Medical Sciences Campus · PRUniversity of Puerto Rico System · PRJohns Hopkins Medicine · USUniversity of Puerto Rico at Río Piedras · PR

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI BENABE, JULIO E, LUCIANO, CARLOS A. · 2012 to 2018
$23.2M
Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., MOROU-BERMUDEZ, EVANGELIA · 2020 to 2024
$17.7M
TRCLU54RR026139 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FRONTERA, WALTER R. · 2010 to 2011
$8.4M
Division of Cancer Epidemiology and Genetics, National Cancer Institute CA096297/CA096300National Institute of Minority Health and Health Disparities 2U54MD007587NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300NCRR NIH HHS U54 RR026139NIGMS NIH HHS U54 GM133807NIMHD NIH HHS U54 MD007587
6 · The paper itself

Abstract

objectiveColorectal cancer is the leading cause of cancer death in Puerto Rico and third among Hispanics in the USA. Up to 2-4% of colorectal cancer cases are a result of Lynch syndrome (LS), a hereditary cancer syndrome caused by a germline mutation in at least one of the DNA mismatch repair genes. The objective of this study was to determine the prevalence of LS in colorectal tumors during the first 15-months after the implementation of universal tumor-based screening for LS in Puerto Rico.

methodsA total of 317 colorectal tumors were evaluated in a large private pathology laboratory from September 2014 to December 2015. Clinical characteristics were obtained from the pathology reports. Unadjusted and adjusted logistic regression models were used to estimate the magnitude of association (odds ratio [OR] with 95% confidence intervals [CI]) between absent MMR protein expression and patient characteristics.

resultsMost cases (93.4%) were analyzed by immunohistochemistry; 11.8% (35 of 296) had deficient mismatch repair protein expression. While 29 of the 317 cases were subjected to PCR-based microsatellite instability analysis of which 10.3% (3 of 317) had microsatellite instability. In total, 11.0% of the tumors were reported MMR deficient. These tumors were more likely from females and more likely localized in the proximal colon compared to those with proficient MMR expression.

conclusionsOur data is consistent with the results from other studies including US Hispanics, where approximately 10% of Hispanic individuals with colorectal cancer have microsatellite instability. Our results support universal tumor-based screening for LS among Hispanics in accordance with National Comprehensive Cancer Network guidelines.

Indexed as

Early Detection of CancerUniversal Health CareAgedColorectal Neoplasms, Hereditary NonpolyposisCross-Sectional StudiesDNA Mismatch RepairFemaleHispanic or LatinoHumansImmunohistochemistryMaleMicrosatellite InstabilityMiddle AgedPuerto RicoColorectal cancerHispanicsLynch syndromeUniversal screening

Identifiers

PMID33006754
PMCPMC8183604
OpenAlexW3089414716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.